Insights Center
Thought leadership, news, events — you will find them all here, right at your fingertips. We’ve consolidated the firm’s most popular content in one, easy to search location. Enter a key word or phrase to find pertinent blog posts, articles, press releases, and upcoming events.
Mintz Viewpoints
Showing 1225 - 1232 of 11439 results
Attorneys Note Rise In Cryptocurrency Whistleblowers
March 3, 2023| News
EPA Pushes Back On State, Industry Bids To Block WOTUS, Citing Status Quo
March 3, 2023| News
FTC Hosts Forum on Proposed Rule to Ban Noncompete Clauses
March 2, 2023| Blog| Viewpoint
What’s New in 5G - March 2023
March 1, 2023| Blog| Viewpoint
New York Proposes Regulatory Review and Approval of Material Health Care Entity Transactions
March 1, 2023| Blog| Viewpoint
An Overview of Why Class Action Privacy Lawsuits May Have Just Gotten Bigger – Yet Again.
March 1, 2023| Blog| Viewpoint
Post-Roe, Prosecutors Can Seek Unprotected Reproductive Health Data
March 1, 2023| News
News & Press Releases
Venture Mega-Rounds Return to Biotech
September 26, 2024
Member Cheryl Reicin was quoted in WSJ Pro Venture Capital in an article about how venture mega rounds are becoming more frequent in the biotech industry. Specifically, Cheryl discusses the need for startups to be aware of the pressures and implications that may come from larger funding rounds.
Mintz Ranked in 2025 Edition of Chambers Canada
September 26, 2024
Mintz announced that it has been ranked in the 2025 edition of Chambers Canada. The firm was rankedin both the Life Sciences and Cannabis Law categories. Six attorneys were also ranked in individual categories including Life Sciences, Private Equity, Investment Funds, Cannabis, and Pensions & Benefits.
Lenovo’s Setback in Ericsson ITC Case May Impact Other SEP Disputes
September 26, 2024
Intellectual Property Division Chair Michael Renaud was quoted by IAM in an article about the ITC case between Ericsson and Lenovo and its potential implications for FRAND negotiations. While most ITC cases involving Standard Essential Patents (SEPs) have resulted in no violation findings, this case could change that.